Depletion of GRIM-19 accelerates hepatocellular carcinoma invasion via inducing EMT and loss of contact inhibition

Journal of Cellular Physiology

Volumn 227, Issue 3, 2012, Pages 1212-1219

  Hao, Hongbo ^a   Liu, Jun ^a   Liu, Guoliang ^a   Guan, Dongshi ^a   Yang, Yang ^b   Zhang, Xiuqing ^a   Cao, Xinmin ^b   Liu, Qian ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; CYTOKERATIN 8; GENES ASSOCIATED WITH RETINOID INTERFERON INDUCED MORTALITY 19 PROTEIN; NERVE CELL ADHESION MOLECULE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL CYCLE S PHASE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CONTACT INHIBITION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NADH, NADPH OXIDOREDUCTASES; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84155184189     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24025     Document Type: Article

References (20)

1. Abercrombie M, Heaysman JE. 1954. Observations on the social behaviour of cells in tissue culture. II. Monolayering of fibroblasts. Exp Cell Res 6: 293-306.
2. Alchanati I, Nallar SC, Sun P, Gao L, Hu J, Stein A, Yakirevich E, Konforty D, Alroy I, Zhao X, Reddy SP, Resnick MB, Kalvakolanu DV. 2006. A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene 25: 7138-7147.
3. Angell JE, Lindner DJ, Shapiro PS, Hofmann ER, Kalvakolanu DV. 2000. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem 275: 33416-33426.
4. Christofori G. 2006. New signals from the invasive front. Nature 441: 444-450.
5. El-Serag HB, Marrero JA, Rudolph L, Reddy KR. 2008. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134: 1752-1763.
6. El-Serag HB, Rudolph KL. 2007. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
7. Fusco A, Viglietto G, Santoro M. 2005. Point mutation in GRIM-19: a new genetic lesion in Hurthle cell thyroid carcinomas. Br J Cancer 92: 1817-1818.
8. Huang Y, Yang M, Yang H, Zeng Z. 2010. Upregulation of the GRIM-19 gene suppresses invasion and metastasis of human gastric cancer SGC-7901 cell line. Exp Cell Res 316: 2061-2070.
9. Kalakonda S, Nallar SC, Gong P, Lindner DJ, Goldblum SE, Reddy SP, Kalvakolanu DV. 2007. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels. Am J Pathol 171: 1352-1368.
10. Martz E, Phillips HM, Steinberg MS. 1974. Contact inhibitions of overlapping and differential cell adhesion: a sufficient model for the control of certain cell culture morphologies. J Cell Sci 16: 401-419.
11. Maximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simoes M. 2005. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 92: 1892-1898.
12. Okamoto T, Inozume T, Mitsui H, Kanzaki M, Harada K, Shibagaki N, Shimada S. 2010. Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth. Mol Cancer Ther 9: 2333-2343.
13. Sun P, Nallar SC, Kalakonda S, Lindner DJ, Martin SS, Kalvakolanu DV. 2009. GRIM-19 inhibits v-Src-induced cell motility by interfering with cytoskeletal restructuring. Oncogene 28: 1339-1347.
14. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev 2: 442-454.
15. Thiery JP, Sleeman JP. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
16. Wang T, Yan XB, Zhao JJ, Ye J, Jiang ZF, Wu DR, Xiao WH, Liu RY. 2011. Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo. Lung Cancer (Amsterdam, Netherlands) 72: 287-293.
17. Yang J, Weinberg RA. 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829.
18. Zhang L, Gao L, Li Y, Lin G, Shao Y, Ji K, Yu H, Hu J, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ. 2008. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth. Clin Cancer Res 14: 559-568.
19. Zhou AM, Zhao JJ, Ye J, Xiao WH, Kalvakolanu DV, Liu RY. 2009a. [Expression and clinical significance of GRIM-19 in non-small cell lung cancer]. Ai zheng=Aizheng=Chin J Cancer 28: 431-435.
20. Zhou Y, Li M, Wei Y, Feng D, Peng C, Weng H, Ma Y, Bao L, Nallar S, Kalakonda S, Xiao W, Kalvakolanu DV, Ling B. 2009b. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers. J Interferon Cytokine Res 29: 695-703.